Role of Prostaglandin E2 in Hypothalamic Fever Regulation and How Antipyretics Interfere
The human body carefully controls its temperature through the hypothalamus. During an infection, this control center raises the temperature set point. Scientists have discovered that Prostaglandin E2 (PGE2) plays a central role in this process.
When the body detects harmful germs, immune cells release special proteins called pyrogens. These pyrogens travel to the brain and trigger the production of PGE2 in the hypothalamus. Moreover, PGE2 then binds to specific receptors in the preoptic area of the hypothalamus. As a result, it raises the body’s temperature set point. The body responds by generating more heat and reducing heat loss. This leads to fever, which helps fight the infection.
PGE2 acts as the main chemical messenger for fever. Without sufficient PGE2, the hypothalamus does not raise the temperature. Researchers therefore consider PGE2 the final mediator of the febrile response.
Antipyretic medicines effectively reduce fever by targeting this pathway. These drugs block the enzyme cyclooxygenase (COX). In addition, they prevent the conversion of arachidonic acid into PGE2. Consequently, PGE2 levels drop in the hypothalamus. The temperature set point returns to normal, and the body cools down through sweating and increased blood flow to the skin.
Common antipyretics work in this way. Paracetamol mainly acts in the brain to lower PGE2 production. Ibuprofen and aspirin inhibit COX enzymes throughout the body, including in the brain. Furthermore, these actions quickly bring down high fever while also reducing pain and inflammation.
However, antipyretics do not treat the underlying infection. They only manage the symptom of fever. Doctors therefore advise using them carefully, especially in children, and always following recommended doses.
In summary, PGE2 serves as a key signal that tells the hypothalamus to create fever. Antipyretics interfere by reducing PGE2 synthesis. This simple yet powerful mechanism helps millions of people feel better during illness. Understanding this process continues to guide the development of safer fever medicines.